| MIR145 |
|
microRNA 145
|
|
|
0.431 |
0.846 |
| MIR375 |
|
microRNA 375
|
|
|
0.476 |
0.769 |
| HPP1 |
|
hyperpigmentation, progressive, 1
|
|
|
0.686 |
0.346 |
| RPL17-C18orf32 |
|
RPL17-C18orf32 readthrough
|
|
0.58 |
0.572 |
0.615 |
| MTCO2P12 |
|
MT-CO2 pseudogene 12
|
|
|
0.368 |
0.962 |
| H3P10 |
|
H3 histone pseudogene 10
|
|
|
0.350 |
0.846 |
| PIK3CD |
O00329
|
phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit delta
|
Kinase
|
1.00 |
0.319 |
0.885 |
| PTGES |
O14684
|
prostaglandin E synthase
|
|
0.71 |
0.540 |
0.769 |
| CFLAR |
O15519
|
CASP8 and FADD like apoptosis regulator
|
Enzyme
|
1.00 |
0.485 |
0.846 |
| COX2 |
P00403
|
cytochrome c oxidase subunit II
|
Enzyme
|
|
0.352 |
0.962 |
| EGFR |
P00533
|
epidermal growth factor receptor
|
Kinase
|
0.37 |
0.295 |
0.885 |
| HRAS |
P01112
|
HRas proto-oncogene, GTPase
|
Enzyme modulator
|
8.0E-02 |
0.378 |
0.885 |
| KRAS |
P01116
|
KRAS proto-oncogene, GTPase
|
Enzyme modulator
|
7.9E-04 |
0.320 |
0.923 |
| NGF |
P01138
|
nerve growth factor
|
Signaling
|
0.82 |
0.391 |
0.885 |
| HMGCR |
P04035
|
3-hydroxy-3-methylglutaryl-CoA reductase
|
|
1.00 |
0.529 |
0.692 |
| TP53 |
P04637
|
tumor protein p53
|
Transcription factor
|
0.53 |
0.236 |
0.962 |
| TYMS |
P04818
|
thymidylate synthetase
|
Enzyme
|
0.72 |
0.425 |
0.846 |
| IGF1 |
P05019
|
insulin like growth factor 1
|
|
0.27 |
0.318 |
0.885 |
| ERCC1 |
P07992
|
ERCC excision repair 1, endonuclease non-catalytic subunit
|
Enzyme
|
1.6E-07 |
0.445 |
0.846 |
| HMGB1 |
P09429
|
high mobility group box 1
|
Nucleic acid binding
|
0.82 |
0.368 |
0.923 |
| AR |
P10275
|
androgen receptor
|
Nuclear receptor
|
0.99 |
0.351 |
0.846 |
| KIT |
P10721
|
KIT proto-oncogene, receptor tyrosine kinase
|
Kinase
|
0.98 |
0.366 |
0.808 |
| HSPA5 |
P11021
|
heat shock protein family A (Hsp70) member 5
|
|
0.77 |
0.434 |
0.885 |
| CDK4 |
P11802
|
cyclin dependent kinase 4
|
Kinase
|
6.3E-02 |
0.412 |
0.808 |
| PCNA |
P12004
|
proliferating cell nuclear antigen
|
Nucleic acid binding
|
0.98 |
0.382 |
0.846 |